Farallon Capital Management LLC Global Blood Therapeutics, Inc. Transaction History

Farallon Capital Management LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$32.4 - $68.18 $14.6 Million - $30.7 Million	450,000 New	450,000 $30.6 Million
Q1 2022 May 16, 2022	BUY	$25.68 - $35.59 $2.13 Million - $2.95 Million	83,004 Added 96.01%	169,458 $5.87 Million
Q4 2021 Feb 14, 2022	SELL	$24.9 - $40.26 $12.8 Million - $20.7 Million	-513,546 Reduced 85.59%	86,454 $2.53 Million
Q3 2020 Nov 16, 2020	SELL	$52.76 - $74.49 $7.91 Million - $11.2 Million	-150,000 Reduced 20.0%	600,000 $33.1 Million
Q4 2019 Feb 13, 2020	SELL	$45.7 - $81.86 $39.4 Million - $70.6 Million	-862,069 Reduced 53.48%	750,000 $59.6 Million
Q3 2019 Nov 14, 2019	BUY	$45.35 - $57.91 $22.1 Million - $28.2 Million	487,069 Added 43.3%	1,612,069 $78.2 Million
Q2 2019 Aug 14, 2019	SELL	$52.6 - $63.29 $19.7 Million - $23.7 Million	-375,000 Reduced 25.0%	1,125,000 $59.2 Million
Q1 2019 May 15, 2019	BUY	$39.99 - $53.48 $2 Million - $2.67 Million	50,000 Added 3.45%	1,500,000 $79.4 Million
Q4 2018 Feb 14, 2019	BUY	$31.54 - $46.67 $2.52 Million - $3.73 Million	80,000 Added 5.84%	1,450,000 $59.5 Million
Q3 2018 Nov 14, 2018	BUY	$38.0 - $51.1 $7.03 Million - $9.45 Million	185,000 Added 15.61%	1,370,000 $52.1 Million
Q2 2018 Aug 14, 2018	BUY	$38.7 - $50.15 $45.9 Million - $59.4 Million	1,185,000 New	1,185,000 $53.6 Million
Q1 2018 May 15, 2018	SELL	$39.6 - $65.9 $13.5 Million - $22.4 Million	-340,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$29.7 - $45.7 $10.1 Million - $15.5 Million	340,000	340,000 $13.4 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Farallon Capital Management LLC with notifications on news.